Here are nine professional athletes who have undergone orthopedic procedures that Becker's has reported on since Oct. 17:
The Latest
Here are four things to know about medtech company Zimmer Biomet, as reported by Becker's since Oct. 28:
A second term under President-elect Donald Trump has a broad range of implications for the direction of healthcare policy and spine care.
From disc replacement to Ozempic, Becker's reported on eight key spine and orthopedic studies since Oct. 28.
Bioretec signed a distribution agreement to accelerate commercialization of the RemeOs trauma screw system in the U.S., according to a Nov. 22 news release.
Velys Spine, the robot from Johnson & Johnson's DePuy Synthes, is slated for a 2025 commercial release.
In the last seven days, Becker's reported on two health systems with big plans for orthopedic facilities.
A lawsuit brought by Geico alleging that an orthopedic surgeon and neurologist filed false claims against the insurance company was dismissed.
The impacts of GLP-1 weight loss drugs like Ozempic and Wegovy on arthroscopy patients are still being studied.
Four key elements have helped Justin Scheer, MD, of Los Angeles-based Cedars-Sinai, assess the value of new spine innovations in a growing landscape.